NASDAQ: CMRXChimerix Inc Stock Ownership - Who owns Chimerix?
Insider buying vs selling
Have Chimerix Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael A. Sherman | Chief Executive Officer | 2025-04-21 | 233,413 | $8.55 | $2.00MSell |
| Michael Albert Alrutz | SVP AND GENERAL COUNSEL | 2025-04-21 | 216,689 | $8.55 | $1.85MSell |
| Robert J. Meyer | Director | 2025-04-21 | 35,150 | $8.55 | $300.53kSell |
| Fred A. Middleton | Director | 2025-04-21 | 40,000 | $8.55 | $342.00kSell |
| Fred A. Middleton | Director | 2025-04-21 | 60,000 | $8.55 | $513.00kSell |
| Fred A. Middleton | Director | 2025-04-21 | 2,776,093 | $8.55 | $23.74MSell |
| Fred A. Middleton | Director | 2025-04-21 | 531,861 | $8.55 | $4.55MSell |
| Fred A. Middleton | Director | 2025-04-21 | 207,523 | $8.55 | $1.77MSell |
| Thomas J. Riga | COO and CCO | 2025-04-21 | 60,828 | $8.55 | $520.08kSell |
| Michael A. Sherman | Chief Executive Officer | 2025-04-21 | 87,000 | $8.55 | $743.85kSell |
CMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CMRX insiders and whales buy or sell their stock.
CMRX Shareholders
What type of owners hold Chimerix Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 9.38% | 8,800,000 | $75.15M | Institution |
| Sanderling Venture Partners V LP | 4.59% | 4,305,046 | $36.77M | Insider |
| Vanguard Group Inc | 4.31% | 4,044,877 | $34.54M | Institution |
| New Leaf Ventures II LP | 4.04% | 3,786,788 | $32.34M | Insider |
| Deerfield Management Company LP Series C | 4.02% | 3,771,342 | $32.21M | Institution |
| Cantex Pharmaceuticals Inc | 3.73% | 3,500,000 | $29.89M | Insider |
| Timothy Wollaeger | 3.55% | 3,330,102 | $28.44M | Insider |
| Rosalind Advisors Inc | 3.25% | 3,050,000 | $26.05M | Institution |
| Monaco Asset Management Sam | 3.01% | 2,820,792 | $24.09M | Institution |
| Canaan VII LP | 2.76% | 2,584,990 | $22.08M | Insider |
CMRX vs Biotech Stocks
Chimerix Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.